NCT05316532View on ClinicalTrials.gov

Novel ECCO2R Device for Hypercapnic Respiratory Failure

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Hypercapnic Respiratory Failure
Interventions
DEVICE

Prismalung + treatment

Low-flow extracorporeal CO2 removal with or without concurrent continuous renal replacement therapy

Trial Locations (1)

9007

RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

Sponsors
All Listed Sponsors
collaborator

Triemli Hospital, Switzerland

UNKNOWN

collaborator

Kantonsspital St. Gallen, St. Gallen, Switzerland

UNKNOWN

collaborator

Baxter International Foundation

UNKNOWN

lead

University of Zurich

OTHER